In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...

Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be ...

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...

Prasad changed jobs but his conservative regulatory doctrine remains the same, particularly for cell and gene therapies. The ...

Today, we’ve got a ton of updates including news about venture capital funding, telehealth policy, the government’s progress ...

Some pharmaceutical companies not targeted by President Trump for agreements to lower U.S. drug pricing aim to craft their ...

BridgeBio Pharma’s experimental drug for the most common cause of dwarfism accelerated children’s growth in a pivotal ...

Digital therapeutics developer Big Health announced Thursday that it has raised $23.7 million from notable investors betting ...

Talkiatry, a virtual psychiatry company, announced Thursday it raised $210 million as it looks to build on its ...

Vinay Prasad is tightening the screws at the FDA, overruling staff and signaling a tougher stance on vaccines and gene ...

Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.

Medicaid cuts in the tax bill Republicans passed last summer are expected to hit rural providers and patients especially hard. Much of those cuts are the result of restrictions on some of the ways ...